{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:41Z","timestamp":1761154301553},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":723,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:sec><jats:title>Bakcground:<\/jats:title><jats:p>Eradication of <jats:italic>Helicobacter pylori<\/jats:italic> infection prevents duodenal ulcer (DU) relapse, but it remains uncertain whether eradication of <jats:italic>H. pylori<\/jats:italic> alone heals duodenal ulceration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To test the hypothesis that eradication of <jats:italic>H. pylori<\/jats:italic> infection is accompanied by healing of duodenal ulcer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A total of 115 consecutive patients with endoscopically confirmed <jats:italic>H. pylori<\/jats:italic>\u2010infected duodenal ulcer were randomly assigned to one of two groups. Group BTC patients received a 1\u2010week course of colloidal bismuth subcitrate 220\u2003mg b.d., tinidazole 500\u2003mg b.d., clarithromycin 250\u2003mg b.d. Group OBTC patients received omeprazole 20\u2003mg daily for 4\u2003weeks with the BTC regimen during the first week. Endoscopy with antral biopsies and <jats:sup>13<\/jats:sup>C\u2010urea breath test (UBT) were performed before and 4\u2003weeks after completion of the 7\u2010day triple or quadruple therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Eight patients dropped out (four in BTC and four in OBTC). Duodenal ulcer healing rates on an intention\u2010to\u2010treat basis in BTC and OBTC were 86% (95% CI: 77\u201395%) and 90% (95% CI: 82\u201398%), respectively. The eradication rates of <jats:italic>H. pylori<\/jats:italic> on an intention\u2010to\u2010treat basis in BTC and OBTC were 88% (95% CI: 79\u201396%) and 91% (95% CI: 84\u201399%), respectively. There were no statistically significant differences in ulcer healing rates and eradication rates between these two groups (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05). Epigastric pain resolved more rapidly in patients assigned to OBTC compared with those assigned to BTC. Both of the two regimens were well tolerated with only minor side\u2010effects (3% of the 115 patients) and the compliance was good.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>BTC is a very effective <jats:italic>H. pylori<\/jats:italic> eradication regimen. Almost all duodenal ulcers heal spontaneously after cure of <jats:italic>H. pylori<\/jats:italic> infection using a 1\u2010week low\u2010dose bismuth\u2010based triple therapy. Treating duodenal ulcer with simultaneous administration of omeprazole achieves ulcer pain relief more rapidly.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00673.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:06Z","timestamp":1047354006000},"page":"53-58","source":"Crossref","is-referenced-by-count":9,"title":["Does eradication of <i>Helicobacter pylori<\/i> alone heal duodenal ulcers?"],"prefix":"10.1111","volume":"14","author":[{"family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.2.179"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)80228-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00251.x"},{"key":"e_1_2_6_6_2","first-page":"1048","article-title":"Double\u2010blind short term trial of furazolidone in peptic ulcer","author":"Zheng ZT","year":"1985","journal-title":"Lancet"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1992.tb01034.x"},{"key":"e_1_2_6_8_2","first-page":"692","article-title":"Toward an optimal treatment of Helicobacter pylori\u2010positive peptic ulcers","volume":"90","author":"Labenz J","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91460-5"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.43"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90929-4"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91301-P"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91545-5"},{"key":"e_1_2_6_14_2","first-page":"1716","article-title":"Meta\u2010analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori","volume":"87","author":"Chiba N","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_15_2","first-page":"505","article-title":"Patient factors affecting Helicobacter pylori eradication with triple therapy","volume":"88","author":"Cutler AF","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_16_2","first-page":"503","article-title":"The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter pylori\u2014a randomized double\u2010blind placebo\u2010controlled clinic trial","volume":"37","author":"Xiao SD","year":"1990","journal-title":"Hepato-Gastroenterology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00487.x"},{"key":"e_1_2_6_18_2","first-page":"A40","article-title":"Efficacy and tolerability of short term, low dose triple therapy for eradication of Helicobacter pylori","volume":"104","author":"Bazzoli F","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0016-5085(90)90983-8","article-title":"Bismuth therapy in gastrointestinal diseases","volume":"99","author":"Sherwood L","year":"1990","journal-title":"Gastroenterology"},{"key":"e_1_2_6_20_2","first-page":"1545","article-title":"Drug therapy for Helicobacter pylori infection. Problems and pitfalls","volume":"85","author":"Glupczynski Y","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_21_2","first-page":"553","article-title":"Colloidal tripotassium dicitrato bismuthate in the treatment of active duodenal ulcer","volume":"27","author":"Turkkan MT","year":"1985","journal-title":"Bull Guthane Mil Med Acad"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00673.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00673.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00673.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:48:53Z","timestamp":1695883733000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00673.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00673.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00673.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}